Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003115 · ClinicalTrials.gov registry record · Phase 3
Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy
A Phase 3 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
NCT00003115 is a Phase 3 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 40 participants.
The verdict
NCT00003115, a Phase 3 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
Study Summary
RATIONALE: Giving hydromorphone in different ways may relieve the pain associated with cancer surgery. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of epidural hydromorphone with hydromorphone infusion in patients with prostate cancer undergoing radical prostatectomy.
Interventions
- DRUG hydromorphone hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 1996-06 |
| Est. Completion | 2004-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003115
The ClinicalTrials.gov registry entry for NCT00003115 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hydromorphone hydrochloride is the first listed.
NCT00003115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003115 about?
NCT00003115 is a clinical study titled "Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy". RATIONALE: Giving hydromorphone in different ways may relieve the pain associated with cancer surgery. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of epidural hydromorphone with hydromorphone infusion in patients with prostate cancer undergoing radical prostatect...
What is the current status of trial NCT00003115?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 1996-06. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00003115?
The interventions under investigation include: hydromorphone hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00003115?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.